Alzheimer's disease & dementia

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.

Medications

This psychoactive drugs trip isn't working

Recreational drug use has been with us forever, and so have the challenges that this use brings to medicine and society. But the nature of the modern drug scene has changed to such an extent that the health systems of the ...

page 35 from 40